Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2001-05-07
2002-09-17
Ford, John M. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
active
06452006
ABSTRACT:
BACKGROUND OF THE INVENTION
A subject-matter of the present invention is a process for the preparation of 5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4(1H,3H)-dione of formula (I):
The compound of formula (I) is known in itself. It can, in particular, be used as intermediate in the synthesis of active compounds which are inhibitors of HIV (Human Immunodeficiency Virus) reverse transcriptase of general formula:
in which
A represents an RaOCH(Rb)— group, where Ra is a (C
1-6
)alkyl group and Rb is a (C
1-4
)alkyl group or a hydrogen atom.
Various processes for the synthesis of the compounds of formula (II) are disclosed in Patents EP 631 783 and JP 080003143 or in Tanaka H. et al.,
J. Med. Chem.
(1995), 38(15), 2860-2865. The starting material used is 5-(1-methylethyl)pyrimidine-2,4(1H, 3H)-dione, an expensive product which has to be prepared in several stages, including a stage of hydrogenation in a highly dilute acidic medium. 5-(1-Methylethyl)pyrimidine-2,4(1H,3H)-dione then leads to the compound of formula (II) in four synthetic stages: alkylation with chloromethyl ethyl ether, condensation of the lithium salt of the first stage with benzaldehyde at a very low temperature and reduction by hydrogenolysis of the benzyl alcohol derivative thus obtained after acetylation of the alcohol functional group by the action of acetic anhydride. The yields are greater than 70-80%, except during the lithiation stage, which involves operating in a dilute medium, at low temperature, using organometallic reagents, such as butyllithium or hexyllithium.
In Danel K. et al.,
J. Med. Chem.
(1996), 39(12), 2427-2431, another way of carrying out the preparation is described which circumvents the obstacle of the lithiation and uses readily accessible starting materials, such as phenylacetonitrile, to which is added ethyl 2-bromo-2-isopropylacetate via a Reformatsky reaction. The intermediate ethyl 2-isopropyl-4-phenylacetoacetate thus prepared is cyclized to 5-(1-methylethyl)-6-(phenylmethyl)-2-thioxo-2,3-dihydropyrimidine-4(1H)-one by the action of thiourea and then, finally, the compound of formula (I) is obtained by the action of chloroacetic acid. This synthesis is ponderous and involves carrying out a Reformatsky reaction on an industrial scale and thus the use of very large amounts of zinc, which is difficult to employ. Furthermore, the desulphurization of 5-(1-methylethyl)-6-(phenylmethyl)-2-thioxo-2,3-dihydropyrimidine-4(1H)-one with chloroacetic acid is accompanied by the formation of chlorothioacetic acid, a product with a nauseating smell. These processes thus comprise numerous stages and use either expensive starting materials or difficult reaction conditions which involve specific safety conditions.
SUMMARY OF THE INVENTION
The Applicant Company has consequently looked for a novel process which obviates the abovementioned disadvantages, making possible simpler, more economical and safer processing.
A first subject-matter of the present invention is consequently a novel process for the preparation of the compounds of formula (I) as defined above and all the alternative forms thereof. Another subject-matter of the invention is novel compounds of use in particular as synthetic intermediates.
DETAILED DESCRIPTION OF THE INVENTION
The process according to the invention is illustrated by the following scheme:
In the context of the present application,
M represents an alkali metal or any other metal of Class II and III of the Periodic Classification of the Elements. More particularly, M represents a manganese, tin, zinc, iron, magnesium or copper atom. X represents a halogen atom, such as chlorine, bromine or iodine,
R
1
represents a halogen atom or an —OR
2
group, where R
2
represents a (C
1-4
)alkyl group,
R
3
represents a (C
1-4
)alkyl group.
The process according to the invention consists in reacting a compound of formula (VI), in which R
1
is as defined above, by coupling with an organometallic compound of formula (V), in which M and X are as defined above, in the presence of a homogeneous metal catalyst, in order to obtain the compound of formula (IV) in which R
1
is as defined above. This coupling process and all the alternative forms thereof come within the scope of the present invention.
At this point, this compound of formula (IV) can either be directly hydrolysed with a strong acid, in an aqueous medium, in an alcoholic solvent such as ethanol or isopropanol, or, when R
1
represents a halogen atom, a dialkoxylation can be carried out by conventional methods known to a person skilled in the art, before carrying out the hydrolysis of this compound obtained of formula (III) under the same hydrolysis conditions as above. This dialkoxylation can be carried out, for example, by the action of alkoxides of formula R
3
ONa according to methods known to a person skilled in the art or by the action of alcohols of formula R
3
OH in the presence of a strong base in aqueous solution, such as dilute sodium hydroxide.
The organometallic compound of formula (V) can be chosen, for example, from: a benzylmagnesium halide or a benzylzinc halide. The benzylmagnesium halide is preferred and more particularly benzylmagnesium chloride is preferred.
According to another specific embodiment of the coupling of the compound of formula (VI) with a compound of formula (V), this coupling can be carried out under the conditions of the Barbier reaction (Barbier P.,
CR,
1899, 128-110), that is to say the addition of a benzyl halide to the compound of formula (VI) in the presence of magnesium turnings, in an appropriate solvent. In the context of the present invention, benzyl chloride is preferred as benzyl halide. This appropriate solvent can be an ether, such as ethyl ether or tetrahydrofuran, or an acetal, such as methylal or ethylal.
According to an advantageous process of the invention, the catalyst is a derivative either of nickel or of palladium. It can be chosen from homogeneous metal catalysts derived either from nickel or from palladium which are complexed with ligands, such as acetylacetone, triarylphosphines or 1,n-bis(diarylphosphino)alkanes, of expanded formula Ni(Acac)
2
, NiCl
2
[PR
3
]
2
, NiBr
2
[PR
3
]
2
, NiCl
2
[R
2
P(CH
2
)
n
PR
2
], Pd[P(R)
3
]
4
, PdCl
2
[PR
3
]
2
, and the like, where Acac is the acetylacetonate group and R is a (C
1-6
)alkyl, aryl or heteroaryl group. The term “aryl group” is understood to mean a carbonaceous aromatic nucleus, for example phenyl, naphthyl or anthracenyl, and the term “heteroaryl group” is understood to mean an aromatic heterocycle, such as, for example, pyridine or thiophene. The preferred catalysts have the following expanded formulae: [CH
3
COCH═C(O—)CH
3
]
2
Ni, NiCl
2
[(C
6
H
5
)
2
PCH
2
—CH
2
P(C
6
H
5
)
2
] or NiCl
2
[(C
6
H
5
)
3
P]
2
.
The reaction according to the invention can be carried out in a polar aprotic solvent (such as tetrahydrofuran, isopropyl ether or diethoxymethane) or in a mixture of polar solvents as defined above and nonpolar solvents, such as aromatic hydrocarbons (toluene, heptane, and the like).
The coupling stage, according to either one of the two alternative forms described above, can be carried out at a temperature of between −80 and +110° C. Generally, the molar ratio of the compound of formula (VI) to the organometallic compound of formula (V) is between 0.5 and 1.5, preferably between 0.9 and 1.2. When the coupling is carried out under the Barbier conditions as described above, the molar ratio of the compound of formula (VI) to the benzyl halide is between 1 and 3, preferably between 1.1 and 1.5, and he molar ratio of the magnesium to the benzyl halide is between 1 and 5, preferably between 1 and 2. The molar ratio of the compound of formula (VI) to the catalyst can be between lo and 30% by weight with respect to the compound of formula (VI). The strong acid used during the hydrolysis can be chosen from hydrochloric acid, hydrobromic acid, sulphuric acid or alkanesulphonic acid, such as methanesulphonic acid.
Adrian Guy
Lecoutteux François
Mignonac Sylviane
Dennison, Schultz & Dougherty
Ford John M.
Sylachim
LandOfFree
Method for preparing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preparing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preparing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2910211